Clinical Trials Directory

Trials / Unknown

UnknownNCT03849495

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults

A Randomized, Open-label, Single Dose, Two-way Crossover Study to Compare the Pharmacokinetics and Safety/Tolerability of CKD-370 With D745 in Healthy Volunteers

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
28 (estimated)
Sponsor
Chong Kun Dang Pharmaceutical · Industry
Sex
All
Age
19 Years – 50 Years
Healthy volunteers
Accepted

Summary

A randomized, open-label, single dose, two-way crossover study to compare the pharmacokinetics and safety/tolerability of CKD-370 with D745 in healthy volunteers

Conditions

Interventions

TypeNameDescription
DRUGCKD-370Test drug
DRUGD745Reference drug

Timeline

Start date
2019-02-19
Primary completion
2019-03-17
Completion
2019-03-21
First posted
2019-02-21
Last updated
2019-03-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03849495. Inclusion in this directory is not an endorsement.

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults (NCT03849495) · Clinical Trials Directory